UNSPSC 51351623: Estradiol dipropionate

This classification denotes a therapeutic estradiol with the molecular formula C24H32O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NIG5418BXB, chemically known as 3,17beta-dihydroxy-1,3,5(10)-estratriene 3,17-dipropionate but more generally known as estradiol dipropionate, which bears US NIH Compound Identifier 3265. European Medicines Agency schedules Estradiol dipropionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22244.

Most nations, for tariff and trade purposes, schedule estradiol dipropionate under HS 29372300. As of Q4 2014, ESTRADIOL DIPROPIONATE remains US FDA's Preferred Term for this commodity. Estradiol dipropionate bears US NLM identifiers UMLS ID C0059618 and NCI Concept Code C29770. SMILES: CCC(=O)OC1CCC2C(C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC(=O)CC)C.

UNSPSC 51351623 Estradiol dipropionate is a Commodity code for a specific pharmaceutical preparation used in hormone-replacement and veterinary applications. State and local governments procure this compound through health departments, correctional facilities, animal-control agencies, and public health clinics to support inmate healthcare, disease-prevention programs, and animal-welfare operations. The solicitations under this code typically specify pharmaceutical-grade formulations meeting USP or equivalent standards, with requirements for proper storage, chain-of-custody documentation, and compliance with state pharmacy regulations.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitations, geographic spread and issuing-body concentration cannot be characterized from current activity.